久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Ajanta Pharma posts jump in consolidated PAT to Rs176.63 crores in Q3 FY2020-21

expresspharmaFebruary 03, 2021

Tag: Ajanta , financial results

Ajanta Pharma has reported financial results for the period ended December 31, 2020.

The company has reported total income of Rs.754.22 crores during the period ended December 31, 2020 as compared to Rs.720.76 crores during the period ended September 30, 2020.

The company has posted net profit / (loss) of Rs.176.63 crores for the period ended December 31, 2020 as against net profit / (loss) of Rs.170.22 crores for the period ended September 30, 2020.

It has has reported total income of Rs.2156.30 crores during the nine months period ended December 31, 2020 as compared to Rs.1941.41 crores during the nine months period ended December 31, 2019.

The company has posted net profit / (loss) of Rs.494.61 crores for the 9 months period ended December 31, 2020 as against net profit / (loss) of Rs.338.54 crores for the 9 months period ended December 31, 2019.

Previous:Just, Evotec Expand mAbs Manufacturing Contract with DOD

Next:EyePoint Announces First Patient Dosed in Trial of EYP-1901 for Wet AMD

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service